Skip header and navigation

Refine By

654 records – page 1 of 66.

1993-1994 influenza season: Canadian laboratory diagnoses, strain characterization and post-season serosurvey (Ontario).

https://arctichealth.org/en/permalink/ahliterature217086
Source
Can Commun Dis Rep. 1994 Oct 30;20(20):177-81
Publication Type
Article
Date
Oct-30-1994
Author
J M Weber
Author Affiliation
National Laboratory for Special Pathogens, Bureau of Microbiology, LCDC, Ottawa, Ontario.
Source
Can Commun Dis Rep. 1994 Oct 30;20(20):177-81
Date
Oct-30-1994
Language
English
French
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Canada - epidemiology
Humans
Influenza A virus - classification
Influenza B virus - classification
Influenza Vaccines - administration & dosage
Influenza, Human - epidemiology - microbiology - prevention & control
Laboratories
Middle Aged
Ontario - epidemiology
Vaccination
Abstract
In Canada as a whole, influenza A/Beijing/32/92-like virus was the dominant infecting strain in the 1993-1994 season with reported laboratory diagnoses peaking in January 1994. Vaccination is again urged for all persons in high-risk groups. Antibody induced by vaccination does not persist well from season to season and the emerging A/Shangdong/9/93 (H3N2)-like variant is related to A/Beijing/32/92(H3N2) but is inhibited less by antibodies to that strain. Conditions are also consistent with possible increased influenza B activity this season.
PubMed ID
7812234 View in PubMed
Less detail

1994-1995 influenza season: Canadian laboratory diagnoses and strain characterization.

https://arctichealth.org/en/permalink/ahliterature214055
Source
Can Commun Dis Rep. 1995 Oct 30;21(20):181-5
Publication Type
Article
Date
Oct-30-1995
Author
J M Weber
Author Affiliation
National Laboratory for Special Pathogens, Bureau of Microbiology, LCDC, Ottawa, Ontario.
Source
Can Commun Dis Rep. 1995 Oct 30;21(20):181-5
Date
Oct-30-1995
Language
English
French
Publication Type
Article
Keywords
Canada - epidemiology
Humans
Incidence
Influenza A virus - isolation & purification
Influenza B virus - isolation & purification
Influenza Vaccines - administration & dosage
Influenza, Human - diagnosis - epidemiology - prevention & control
Seasons
PubMed ID
8563690 View in PubMed
Less detail

2005-06 Influenza Vaccine: Indications & Administration

https://arctichealth.org/en/permalink/ahliterature87934
Source
Bulletin No.22
Date
8 September 2005
  1 website  
Author
State of Alaska, DPH, Section of Epidemiology
Source
Bulletin No.22
Date
8 September 2005
Language
English
Geographic Location
U.S.
Physical Holding
University of Alaska Anchorage
Keywords
influenza, vaccine, vaccination, flu
Online Resources
Less detail

The 2009 H1N1 Influenza Pandemic: the role of threat, coping, and media trust on vaccination intentions in Canada.

https://arctichealth.org/en/permalink/ahliterature117388
Source
J Health Commun. 2013;18(3):278-90
Publication Type
Article
Date
2013
Author
Sheena Aislinn Taha
Kimberly Matheson
Hymie Anisman
Author Affiliation
Department of Neuroscience, Carleton University, Ottawa, Ontario, Canada. sheena_taha@carleton.ca
Source
J Health Commun. 2013;18(3):278-90
Date
2013
Language
English
Publication Type
Article
Keywords
Adaptation, Psychological
Adult
Canada - epidemiology
Female
Humans
Influenza A Virus, H1N1 Subtype - immunology
Influenza Vaccines - administration & dosage
Influenza, Human - epidemiology - prevention & control - psychology
Intention
Male
Mass Media
Pandemics - prevention & control
Public Opinion
Questionnaires
Risk assessment
Trust
Vaccination - psychology
Abstract
Swine flu (H1N1) reached pandemic proportions in 2009, yet ambivalence was met concerning intentions to be vaccinated. The present investigation determined predictors of perceived H1N1 contraction risk and vaccination intentions among Canadian adults (N = 1,027) responding to an online questionnaire. The relatively low rate of vaccination intent (30.12%, and 34.99% being unsure of their intent) was related to a sense of invulnerability regarding illness contraction and symptom severity. Most individuals were skeptical that H1N1 would be widespread, believing that less than 10% of the population would contract H1N1. Yet, they also indicated that their attitudes would change once a single person they knew contracted the illness. Also, worry regarding H1N1 was related to self-contraction risk and odds of individuals seeking vaccination. Moreover, vaccination intent was related to the perception that the threat was not particularly great, mistrust of the media to provide accurate information regarding H1N1, and whether individuals endorsed problem-focused versus avoidant coping strategies. Given the role media plays in public perceptions related to a health crisis, trust in this outlet and credibility regarding the threat are necessary for adherence to recommended measures to minimize health risk.
PubMed ID
23301849 View in PubMed
Less detail

The 2009 Provincial decision to de-emphasize seasonal influenza vaccine in Canada: real-time risk-benefit analysis.

https://arctichealth.org/en/permalink/ahliterature136573
Source
Clin Infect Dis. 2011 Mar 15;52(6):829-30; author reply 830-1
Publication Type
Article
Date
Mar-15-2011
Author
Perry R W Kendall
Source
Clin Infect Dis. 2011 Mar 15;52(6):829-30; author reply 830-1
Date
Mar-15-2011
Language
English
Publication Type
Article
Keywords
Canada
Humans
Influenza A Virus, H1N1 Subtype - immunology
Influenza Vaccines - administration & dosage - adverse effects - immunology
Influenza, Human - epidemiology - prevention & control - virology
Pandemics
Risk assessment
Vaccination - utilization
Notes
Comment On: Clin Infect Dis. 2010 Dec 15;51(12):1380-221067354
PubMed ID
21367739 View in PubMed
Less detail

[About the estimation of non specific protective effect of vaccination against infections actual for military personnel].

https://arctichealth.org/en/permalink/ahliterature118396
Source
Voen Med Zh. 2012 Oct;333(10):40-6
Publication Type
Article
Date
Oct-2012
Author
G G Mar'in
O A Gruzdeva
V V Valevskii
N N Tsapkova
V V Alekseev
A A Sobolev
M A Sokolov
D V Sibilev
Source
Voen Med Zh. 2012 Oct;333(10):40-6
Date
Oct-2012
Language
Russian
Publication Type
Article
Keywords
Adolescent
Adult
Humans
Influenza Vaccines - administration & dosage
Influenza, Human - mortality - prevention & control
Male
Mass Vaccination - methods
Military Medicine
Military Personnel
Russia - epidemiology
Abstract
Flue and other respiratory diseases morbidity of servicemen of training students are researched. Epidemiological and economic effectiveness of flue vaccine "Bakcuspun" (Vaksigrip) is estimated. Its non-specific protective effect in case of acute respiratory diseases and pyodermia is shown.
PubMed ID
23213772 View in PubMed
Less detail

Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match.

https://arctichealth.org/en/permalink/ahliterature194986
Source
Vaccine. 2001 Apr 30;19(23-24):3253-60
Publication Type
Article
Date
Apr-30-2001
Author
R. Pyhälä
M. Haanpää
M. Kleemola
R. Tervahauta
R. Visakorpi
L. Kinnunen
Author Affiliation
National Public Health Institute, Helsinki, Finland. reijo.pyhala@ktl.fi
Source
Vaccine. 2001 Apr 30;19(23-24):3253-60
Date
Apr-30-2001
Language
English
Publication Type
Article
Keywords
Adult
Amino Acid Sequence
Antibodies, Viral - blood
Antigens, Viral - genetics
Base Sequence
DNA Primers - genetics
Disease Outbreaks
Finland - epidemiology
Genes, Viral
Humans
Influenza A virus - genetics - immunology - isolation & purification
Influenza Vaccines - genetics - immunology - pharmacology
Influenza, Human - epidemiology - immunology - prevention & control - virology
Male
Military Personnel
Molecular Sequence Data
Phylogeny
Abstract
Commercial inactivated parenteral influenza vaccines reduced febrile (> or = 38 degrees C) respiratory illness by 53% (95% CL: 41-63%) during a 3 week outbreak in 1998 when A/Sydney/5/97(H3N2)-like influenza viruses were shown to be the predominant etiological agents and an older antigenic variant, A/Nanchang/933/95, served as the vaccine virus. The calculatory efficacy for preventing virologically diagnosed influenza infections was 57% (95% CL: 40-68%). The study population consisted of 1374 young male military conscripts. Vaccination coverage on a voluntary basis was 67%. Vaccination was ineffective in preventing febrile illness during a second epidemic wave lasting 2 weeks when mainly adenoviruses were shown to have been circulating in the garrison. Out of the 36 nasopharyngeal aspirates positive for influenza A by antigen detection, 18 A/Sydney/5/97-like strains (10 from non-vaccinated and eight from vaccinated subjects) and two A/Nanchang/933/95-like strains (both from non-vaccinated subjects) were isolated in MDCK cell cultures. Intraepidemic variation was detected among the A/Sydney/5/97-like field strains in their HA1 sequences and reactivity in HI tests, but no evidence was obtained that this variation would have been of significance to the virus in breaking through the vaccination-induced immunity.
PubMed ID
11312022 View in PubMed
Less detail

[A comparative study of live and inactivated influenza vaccines: the organization of the observation and the results of a study of their reactogenicity and immunogenicity].

https://arctichealth.org/en/permalink/ahliterature218231
Source
Vopr Virusol. 1994 May-Jun;39(3):129-31
Publication Type
Article
Author
A N Slepushkin
L G Rudenko
A P Kendal
A S Monto
A L Beliaev
E I Burtseva
E P Grigor'eva
N P Obrosova-Serova
V T Ivanova
V E Bragina
Source
Vopr Virusol. 1994 May-Jun;39(3):129-31
Language
Russian
Publication Type
Article
Keywords
Adolescent
Antibodies, Viral - blood
Antibody Specificity
Child
Drug Evaluation
Humans
Influenza A virus - immunology
Influenza B virus - immunology
Influenza Vaccines - adverse effects - immunology
Influenza, Human - prevention & control
Russia
Urban Population
Vaccines, Attenuated - adverse effects - immunology
Vaccines, Combined - adverse effects - immunology
Vaccines, Inactivated - adverse effects - immunology
Abstract
Schoolchildren of 30 to 34 schools of Novgorod were vaccinated over a three-year period with Russian live cold-adapted attenuated vaccine for children and whole-virus inactivated vaccines and placebo for comparative field study of the vaccines properties and efficacy. In control trials both bi- and trivalent live attenuated vaccines were well tolerated and areactogenic. A whole-virus inactivated trivalent vaccine induced mild and moderate fever and local reactions in 2-4% of the vaccinees. Special observations are necessary to establish the possibility of use and to determine a dose of this inactivated vaccine for immunization of children, especially those of 7-10 years of age. All the vaccines induced HI antibody production in 50-80% and antineuraminidase in 50-70% of seronegative children. The pattern of the results was similar to that in revaccinated children with preexisting antibody at a level of 1:20, but much lower in children with the initial titre above 1:20. After the 3rd year of vaccination the immune response of the vaccinees was similar, most of the results depending on the initial antibody titre and also on the change of vaccine strains. This raises a question of the expediency of annual influenza revaccination of the same person after 2 years of successful immunization and of the necessity of vaccine strains replacement after 2-3 years of use.
PubMed ID
8091754 View in PubMed
Less detail

[A comparative study of the inoculation properties of live recombinant and inactivated influenza vaccines made from strain A/Philippines/2/82 (H3N2) in 8- to 15-year-old children].

https://arctichealth.org/en/permalink/ahliterature225785
Source
Vopr Virusol. 1991 Sep-Oct;36(5):372-4
Publication Type
Article
Author
A N Slepushkin
N P Obrosova-Serova
E I Burtseva
E A Govorkova
L G Rudenko
R V Vartanian
A I Vereshchinskii
M D Musina
N I Lonskaia
L A Zazimko
Source
Vopr Virusol. 1991 Sep-Oct;36(5):372-4
Language
Russian
Publication Type
Article
Keywords
Adolescent
Antibodies, Viral - blood
Child
Disease Outbreaks - prevention & control
Humans
Influenza Vaccines - adverse effects - immunology
Influenza, Human - prevention & control
International Cooperation
Moscow
Orthomyxoviridae - immunology
United States
Vaccines, Inactivated - adverse effects - immunology
Vaccines, Synthetic - adverse effects - immunology
Abstract
This study was carried out to compare reactogenicity, immunogenicity, and efficacy of live attenuated and inactivated influenza vaccines prepared from influenza A/Philippines/2/82-like virus strains. Schoolchildren of a boarding school of Moscow were randomly divided into three groups: (1) vaccinated with a live attenuated vaccine, (2) vaccinated with inactivated influenza vaccine, and (3) given placebo. Both vaccines were well tolerated by the children, with practically no severe general or local reactions. The inactivated vaccine was found to be superior to the live one in its capacity to stimulate humoral immunity studied by HI, EIA, and microneutralization tests. In 69.7% of the children given the inactivated vaccine, seroconversion to the vaccine strain was detected by two or three methods of antibody titration used. Only 35.4% seroconversions were demonstrated in children immunized with the live influenza vaccine. Enzyme immunoassay was found to be a more sensitive but less specific method for antibody titration as compared with HI test whereas microneutralization proved to be more specific but less sensitive for titration of antibodies to influenza A (H3N2) viruses.
PubMed ID
1803766 View in PubMed
Less detail

654 records – page 1 of 66.